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Objectives: Complex EVAR involving fenestrated and
branched endografts, is associated with significant post
operative complications. Increased use of iodinated con-
trast medium is associated with post operative contrast
medium induced renal dysfunction and renal failure. We
describe the use of CO2 as the primary contrast agent in
patients undergoing complex EVAR.
Methods: Two cohorts of patients undergoing fenes-
trated and branched EVAR were compared at a regional
vascular unit. 68 complex endografts were implanted be-
tween 2008 and 2010; 41 procedures were completed with
iodinated contrast media (group 1) and 27 utilised CO2 as
the primary contrast agent (group 2). Endpoints assessed
were need for renal replacement therapy or renal impair-
ment, defined as increase in creatinine of 25%.
Results: Baseline renal function was similar in each
group (creatinine group 1 median96; group 2 me-
dian102, (P0.21)). There was a significant difference in
the median change in post op creatinine (28.5 in group 1
compared to 9.5 in group 2 (P0.048)). However, there
was no significant difference in postoperative renal dys-
function (13/41 in group 1 and 8/27 in group 2
(P0.79)) or need for temporary renal support (7/41 in
group 1 and 3/27 in group 2 (P0.72). No patients
required permanent dialysis. Median volume of iodin-
ated contrast used fell from 226.25ml to 75ml (p0.43).
There was no difference between the groups in fluoros-
copy time or radiation dose.
Conclusions: Renal impairment is a common post-
operative complication amongst patients undergoing
complex EVAR, although its aetiology is multi-factorial.
CO2 angiography can be successfully used for complex
EVAR and its use may reduce the volume of iodinated
contrast used as well as lower post operative creatinine
levels.
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Objectives: The choice between endovascular (EVAR)
and open repair (OAR) to treat abdominal aortic aneu-
rysm (AAA) is frequently dependent on periprocedural
morbidity and mortality. Previous randomized clinical
trials have demonstrated better short-term outcomes
with EVAR. The objective of this study was to report the
contemporary 30-day morbidity and mortality of AAA
repair in the United States population comparing EVAR
and OAR.
Methods: Patients who underwent infrarenal AAA
repair were identified from the 2007-09 National
Surgical Quality Improvement Program - a multicenter
(more than 180 hospitals), prospective database. Univar-
iate and multiple logistic regression analyses were
performed.
Results: Of total 10,251 patients, 72% underwent
EVAR. Patients undergoing EVAR were more commonly
males (83.3% vs 74.4%), octogenarians (29.3% vs 16.7%),
and had a higher percentage of iliacs/femorals as attach-
ment site (92.5% vs 43.5%). They had less intraoperative
transfusion (median 0 vs 2 units), operative time (141 vs
211 minutes), hospital length of stay (median 2 vs 7 days),
and return to operating room (4.2% vs 8.0%). On univariate
analysis, 30-day major morbidity and mortality were lower
for EVAR (8.9% vs 24.7% and 1.2% vs 3.3%, respectively;
p0.0001 for both). After controlling for 65 comorbidi-
ties and procedural characteristics on multivariate analy-
sis, OAR was associated with higher postoperative major
morbidity (OR 1.8; 95%CI- 1.5 to 2.0; p0.0001;
c-statistic: 0.73); however, a significant difference was
not seen between OAR and EVAR for postoperative
mortality (OR 1.4; 95%CI - 0.99 to 1.99; p0.06;
c-statistic 0.81).
Conclusions:Contemporary outcomes following AAA
repair in the United States continue to be excellent. After
controlling for other factors, EVAR and OAR procedures
have similar perioperative mortality rates. OAR was, how-
ever, independently associated with 1.8 times higher peri-
operative morbidity. These data demonstrate that elective
EVAR has short-term morbidity benefits compared with
OAR.
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